Back to News
Market Impact: 0.3

Guru Fundamental Report for HIMS

HIMSNDAQ
Company FundamentalsAnalyst InsightsMarket Technicals & FlowsHealthcare & Biotech
Guru Fundamental Report for HIMS

HIMS & HERS HEALTH (HIMS), a large-cap biotech growth stock, scored 77% on Validea's Quantitative Momentum Investor model, based on Wesley Gray's strategy. While the stock passed core momentum criteria, this 77% rating falls just below the 80% threshold typically indicating 'some interest,' with 'Return Consistency' and 'Seasonality' noted as neutral, suggesting it doesn't fully meet the higher conviction criteria of this specific quantitative momentum approach.

Analysis

HIMS & HERS HEALTH INC (HIMS), a large-cap growth stock in the Biotechnology & Drugs sector, scores 77% on Validea's Quantitative Momentum Investor model, which is based on the strategy of Wesley Gray. This score, while moderately positive, falls just short of the 80% threshold that the model typically requires to indicate 'some interest' and well below the 90% 'strong interest' level. The stock successfully passed the core 'Twelve Minus One Momentum' criterion, signaling strong intermediate-term relative performance. However, the overall rating was constrained by 'Neutral' assessments for 'Return Consistency' and 'Seasonality'. This specific combination suggests that while HIMS exhibits favorable momentum characteristics, it does not fully meet the model's requirements for a high-conviction position due to a lack of consistent return patterns and the absence of positive seasonal tailwinds.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.40

Ticker Sentiment

HIMS0.40
NDAQ0.00

Key Decisions for Investors

  • Momentum-focused investors should recognize that while HIMS shows positive relative strength, its neutral ratings for consistency and seasonality prevent it from being a high-conviction pick under this specific quantitative model.
  • The 77% score can be interpreted as a moderately bullish signal, but it warrants caution; investors should weigh the strong price momentum against the identified lack of return stability before building a position.
  • Consider monitoring HIMS for improvements in its return consistency, as a positive shift in this metric could elevate its quantitative score and potentially attract increased interest from systematic investment strategies.